A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Desflurane (SUPRANE)

Desflurane induces unconsciousness for surgical procedures.

First FDA approval1992-09-18
Generic availableYes · 1 mfrs
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one
Lowest NADAC
/unit
0 NDCs benchmarked, lowest of all strengths.
Average NADAC
Across all dosage forms in distribution.
Highest NADAC
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema10 entries indexed · 4 visible
What is Desflurane used for?

Desflurane induces unconsciousness for surgical procedures.

Is there a generic for Desflurane?

Yes. 1 ANDAs filed at FDA, 1 generic manufacturers currently shipping.

How much does my plan pay for Desflurane?

NADAC pricing data not currently available for this drug.

Is Desflurane on the FDA shortage list?

No. Desflurane is not currently on the FDA Drug Shortage Database.

6 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

General Anesthetic6 alternatives in D1
01
Amidate(Tm) Etomidate
General Anesthetic
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
02
Etomidate
Brand: Amidate
Lowest NADAC
7Generic mfrs
CY24 Part D spend
Compare →
03
Etomidate Injection
Brand: Etomidate
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
04
Etomidate Injection, Solution
General Anesthetic
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
05
Isoflurane
Brand: FORANE
Lowest NADAC
4Generic mfrs
CY24 Part D spend
Compare →
06
Ketamine
Brand: KETALAR
$0.521Lowest NADAC
7Generic mfrs
CY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (2 approvals on file) · NADAC unit costs: CMS NADAC weekly file · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.